The 2019 Corrona PsA-SpA
Registry Investigator Meeting
The New York Athletic Club
Saturday September 7, 2019
8:00 a.m. – 2:00 p.m.
Generating the Evidence that Payers, PBMs, Caregivers, and Patients Need in Major Autoimmune Diseases: Implications for the Pharmaceutical Industry
With the proliferation and approval of additional biologic and targeted therapies in autoimmune diseases, clinicians, payers, and patients are faced with a dizzying array of therapeutic options. For rational decision-making, it is apparent that head-to-head studies of biologic therapies are ideal and the ‘gold standard’ for evidence-based decision-making.
Autoimmune diseases pose significant challenges to health care and no one entity will solve these alone. The answer lies not just in new clinical advances, but in expanding our collective capability to enhance patient treatment and outcomes through data analytics and evidence-based medicine. Health care has only begun to scratch the surface of the true potential of data analytics. Our discussions must ultimately address solving the barriers to an evidence-based approach.
—Roy A. Beveridge, MD, Senior Vice President & Chief Medical Officer, Humana
However, there is an emerging gap in the evidence generated from RCTs. For example, the majority of clinical trials do not compare biologic drugs against one another, but rather versus either a placebo or single active comparator. Further, many RCTs show similar outcomes across different therapeutic options for autoimmune diseases. For instance, in the treatment of RA we frequently see the same “60-40-20” response rates across ACR 20, 50 and 70 outcomes respectively with all interventions. This situation begs the question of whether we are using the right data sources, and the right measures to capture meaningful differences.
We believe that more attention needs to be:
- Focused on assessing the potential for real world outcomes data to help distinguish meaningful differences that are not readily apparent in randomized controlled trials
- Acknowledging the data gaps and how should they be filled
- Assessing how real world outcomes data can complement data gathered from RCTs
Saturday, September 7, 2019
Morning Agenda: 8:15 AM – 12:00 PM
Jeffrey Greenberg, MD, MPH, Corrona Chief Medical Officer
Philip Mease, MD, Director, Rheumatology Research Division, Swedish Medical Center/Providence St. Joseph Health, Professor of Medicine, University of Washington
Paul Caldron, DO, PhD, Clinical Associate Professor, Midwestern University Arizona College of Osteopathic Medicine, Clinical Assistant Professor, University of Arizona College of Medicine, Arizona Arthritis and Rheumatology Associates, PC
Focus Group Breakout Session (Group 1 = Investigators & Group 2 = Coordinators)
Corrona moderators will facilitate information sharing among registry colleagues through break out groups based on registry role.
Moderator: Joel Kremer, MD, Corrona Founder. A site panel will be available to answer questions and lead discussions based on information presented throughout the day.
Afternoon Agenda: 12:45 PM – 2:00 PM
Bruce Strober, MD, PhD, Central Connecticut Dermatology, Clinical Professor of Dermatology, Department of Dermatology UConn Health
Philip Mease, MD, & Jeffrey Greenberg, MD, MPH
Jeffrey Greenberg, MD, MPH
Chief Medical Officer
Dr. Greenberg is Chief Medical Officer with Corrona, and holds an appointment as Clinical Associate Professor of Medicine at New York University School of Medicine. Dr. Greenberg continues to see patients at the Institute for Rheumatic and Autoimmune Diseases at Overlook Hospital in New Jersey. Dr. Greenberg has published more than 100 peer-reviewed manuscripts, as well as textbook chapters, primarily focused on rheumatoid arthritis and psoriatic arthritis.
Paul H. Caldron, DO, PhD, FACP, FACR, MBA
Clinical Associate Professor, Midwestern University Arizona College of Osteopathic Medicine,
Clinical Assistant Professor, University of Arizona College of Medicine, Arizona Arthritis and Rheumatology Associates, PC
Paul Caldron is certified in internal medicine and rheumatology, having trained in both areas at the Cleveland Clinic. He practices clinical rheumatology and performs clinical research at Arizona Arthritis and Rheumatology Associates. He is Clinical Associate Professor at University of Arizona College of Medicine and Clinical Assistant Professor at Midwestern University Arizona College of Osteopathic Medicine. Other qualifications include an MBA in international management as well as a PhD in governance and policy analysis.
Philip J. Mease, MD
Dr. Mease received undergraduate and medical degrees from Stanford University, completed residency in internal medicine and fellowship in rheumatology at the University of Washington, directs the rheumatology research division at Swedish Medical Center/Providence St. Joseph Health and is Clinical Professor of Medicine at the University of Washington in Seattle. His major research interests include psoriatic arthritis (PsA) and spondyloarthritis (SpA). His work includes research on disease state, development of outcome measures, and determining the efficacy and safety of emerging therapies for these conditions. He has authored over 450 journal articles, numerous abstracts, and book chapters. He is past president, founding organizer and current treasurer of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and member of its Collaborative Research Network (CRN) steering committee. He is a member of the Assessment of Spondyloarthritis international Society (ASAS) and the Spondyloarthritis Research and Treatment Network (SPARTAN). He is active in the Outcome Measures in Rheumatology Clinical Trials (OMERACT) organization as co-chair of the PsA and chronic pain working groups, and steering committee member. He is the scientific director of the PsA and SpA arms of the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
Bruce E. Strober, MD, PhD, FAAD
Clinical Professor of Dermatology, Department of Dermatology, UConn Health, Farmington, CT
Central Connecticut Dermatology, Cromwell, CT
Bruce E. Strober, MD, PhD, FAAD, is Clinical Professor of Dermatology at UConn Health in Farmington, Connecticut and Director of Clinical Trials at Central Connecticut Dermatology Research. He earned his medical degree and PhD at Columbia University College of Physicians and Surgeons in New York, New York. Dr. Strober completed his internship in Internal Medicine, residency in Dermatology, and fellowship in Dermatopharmacology at the NYU School of Medicine in New York. He is board-certified in Dermatology by the American Board of Dermatology.
Dr. Strober is a Fellow of the American Academy of Dermatology, the Co-Scientific Director of the Corrona Psoriasis Registry and a board member and Secretary-Treasurer for the International Psoriasis Council.
Dr. Strober’s research interests include the study of therapeutics, both old and new, for inflammatory skin disease, specifically interventions that help patients with difficult-to-treat psoriasis, alopecia areata, atopic dermatitis, and hidradenitis suppurativa. Additional research interests include elucidation of novel features of inflammatory skin disease not previously uncovered and assisting in the clarification of the pathophysiology of inflammatory skin disease. He has served as principal investigator or sub-investigator for numerous multicenter clinical studies.
Dr. Strober has served as a Section Editor for the British Journal of Dermatology, and is an ad hoc reviewer for the New England Journal of Medicine, the Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, and Inflammation. He has published more than 150 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, the New England Journal of Medicine, Journal of the American Academy of Dermatology, and the Journal of Investigative Dermatology, the Journal of the American Medical Association, among others. Dr. Strober also has presented data to the FDA on behalf of multiple pharmaceutical companies, including at the advisory committee for secukinumab, a novel IL-17 inhibitor.
His primary clinical focus is the treatment of moderate-to-severe plaque psoriasis and atopic dermatitis.
The New York Athletic Club’s (NYAC) City House
Located in mid-town Manhattan, across the street from famed Central Park
The NYAC’s City House is a 24 story, purpose-built facility, housing superb dining facilities, inviting over-night guest rooms and athletic facilities beyond compare.
The New York Athletic Club’s (NYAC) City House boasts panoramic views of Central Park, top class facilities for the Club’s members and guests and is ideally situated for those wishing to take advantage of all the sights and sounds that New York City has to offer.
The City House of the New York Athletic Club is an elegant, formal building in the grand tradition of New York City. When visiting the City House, members and guests will be expected to dress, at all times, in a refined and appropriate manner.
- Gentlemen - Jackets are optional in most areas. Slacks, a collared shirt and dress shoes are permitted. Shirts must be tucked in. Jackets are required in the Main Dining Room and Cocktail Lounge.
- Ladies - Permitted attire refers to business suits, tailored pant or skirt ensembles, and dresses. Spandex, open midriffs, halter tops, leggings, denim and extremely short hemlines (more than 3" above the knee, as a guideline) are not permitted.
- Jeans, T-shirts, sneakers and flip-flops are prohibited.
Please visit the NYAC’s website for full details for dress code requirements. https://www.nyac.org/dress-code
THE NEW YORK ATHLETIC CLUB | CITY HOUSE - PARKING
The New York Athletic Club’s (NYAC) is affiliated with a local parking garage that is located on 58th Street just before and just after 7th Avenue. To access the garage, turn right on 58th Street just before 7th Avenue. The rear entrance to the NYAC is located on 58th Street just after you cross 7th Avenue. If you get your parking ticket validated by the NYAC front desk you may be eligible to receive a discounted rate at GMC Parking.
GMC Parking | (212) 265-1078
200 Central Park South
Between Broadway & 7th
Hours of Operation: 24hrs / 7 Days a week
Cost w/ NYAC Validation: Approximately $37 + tax (full day)
Cost w/out NYAC Validation: Approximately $47 + tax (full day)
Please be sure to validate your parking ticket at the front desk of the NYAC. Visit their website for more details http://www.gmcparking.com/locations-and-rates/upper-west-side/64/
There is an additional parking garage between 6th and 7th Avenues.
Quick Park | (212) 977-7422
125 West 58th Street
Between 6th and 7th Avenue
Hours of Operation: 24hrs / 7 Days a week
Approximately $30 + tax (full day)
Quik Park is a subsidiary of Icon Parking Systems. You can visit their website for more details https://iconparkingsystems.com/
Please visit the NYAC’s website for driving directions. https://www.nyac.org/directions
We have partnered with FCM to coordinate your travel to the investigator meeting in New York City. You can contact them via phone or email (both provided below) anytime during the hours listed. An FCM team member will assist you with your travel arrangements.
FCM Office Contact Details and Hours
Hours: Monday — Friday 8:30 AM — 6:30 PM ET
T: +1 888-308-3294 (option 2)
Transportation from and to the airport
We kindly ask that you take an Uber or taxi to/from the airport to the New York Athletic Club. Please send your receipt and complete the expense form that was provided to you in the registration email.
All meeting guests will be staying on site at the New York Athletic Club. We here at Corrona will be making sleeping room reservations for you.
Please indicate on the room type section of the registration page if you prefer a king or double-bedded room. Please note that there is a very limited number of double-bedded rooms, so be sure to request one ONLY if truly needed.
Check-In & Out
Check-in time for all rooms is 3:00pm and check-out time is 12:00 noon.
Extending your stay?
A limited number of rooms are available pre and post the event date. If you would like to extend your stay, please indicate so on the housing section of the registration page. Someone will be in touch with you to collect your credit card information and advise you of the room rate. The average room rate for the dates surrounding the meeting is approximately $415.00 per night plus New York State and City tax and hotel fees.
Members and guests are expected to dress in a refined and appropriate manner, using “Professional/Corporate or Evening Wear” at all times. Jeans of any color are never permitted. Please see more about the dress code on the “Venue” page.
Rooms are equipped with large screen televisions, unlimited complimentary Wi-Fi, Keurig coffee makers and many other amenities, including complimentary newspapers. Overnight guests also enjoy access to the Club’s storied athletic facilities, restaurants and lounges.
Is there a fee for attending the PsA/SpA Investigator Meeting?
There is no charge to attend the PsA/SpA Investigator Meeting. Transportation, parking, lodging and meals during the PsA/SpA Investigator Meeting (September 7th) will be provided by Corrona. Any meals, transportation, activities or additional hotel nights outside of the meeting date will not be reimbursed by Corrona. For additional questions, please feel free to reach out to Elizabeth Guilbeault, Sr. Event Manager, at email@example.com.
What is the dress code?
Business Casual. Please visit the NYAC website at https://www.nyac.org/dress-code for full details on our venue's specific requirements on dress code.
Will there be private ground transportation provided to/from the airport to the NYAC?
No, private group transportation will not be provided for this meeting. You are encouraged to take Uber or a taxi and submit those charges for reimbursement.
Will meals be provided?
Breakfast and lunch will be provided as part of the program. Please let us know of any dietary restrictions during the registration process. You may email Vanessa Lewis at firstname.lastname@example.org for specific instructions.
Who can I contact with any questions?
Please email Vanessa Lewis at email@example.com